Are you travelling to Qatar soon and wanting to check if you need to undergo hotel quarantine or not after your arrival in the country? Check the below latest guidelines from the Ministry of Public Health (MoPH) regarding the COVID-19 quaran..
Expatriates, who are unable to come back to Oman due to the current entry ban on passengers from certain countries, are hopeful that they will be allowed to return soon, after other Gulf countries loosened entry restrictions. Qatar, Kuwait, and th..
REUTERS Moderna Inc (MRNA.O) said on Thursday its COVID-19 shot was about 93% effective through six months after the second dose, showing hardly any change from the 94% efficacy reported in its original clinical trial. However, it sai..
REUTERS Germany, France and Israel will go ahead with plans to administer COVID-19 vaccine boosters, disregarding an appeal by the World Health Organisation to hold off until more people are vaccinated around the world. The decision to press ah..
SYDNEY, Aug 6 - President Joe Biden told a forum of Pacific island leaders in a recorded message on Friday that their countries would benefit from U.S. donated COVID-19 vaccines distributed without political strings. China has in recent years beco..
Aug 6 - United Airlines Inc (UAL.O) on Friday became the latest company to require all its U.S.-based employees to be fully vaccinated against COVID-19. The airline said employees would need to show proof of vaccination, five weeks after the U.S. ..
Saudi Arabia has decided to allow entry to foreign travellers fully vaccinated with either Sinopharm or Sinovac vaccines, provided that they also receive a booster shot of either of the four vaccines approved by the Kingdom, according to the country&..
REUTERS The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19. Moderna's (MRNA.O) vaccine may be best against Delta The mRNA vaccin..
REUTERS South Korea gave vaccine developer SK Bioscience (302440.KS) the green light on Tuesday for a Phase III study of its COVID-19 vaccine candidate at a time of vaccine shortages, when a spurt in infections is fuelling demand. The..